Genetic determinants of hearing loss associated with vestibular schwannomas

Otology and Neurotology

Volumn 30, Issue 5, 2009, Pages 661-667

  Stankovic, Konstantina M ^a,b   Mrugala, MacIej M ^b   Martuza, Robert L ^b   Silver, Michael ^b   Betensky, Rebecca A ^b   Nadol Jr , Joseph B ^a,b   Stemmer Rachamimov, Anat O ^b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carcinoembryonic antigen; Hearing loss; Peroxisomal biogenesis factor 5 like; Platelet factor 4; Prostate specific membrane antigen like; RAD54B; Vestibular schwannoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN BETA POLYPEPTIDE 4; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; LONG CHAIN ACYL COA SYNTHETASE 2; LONG CHAIN FATTY ACID COENZYME A LIGASE; MEMBRANE PROTEIN; NUCLEIC ACID BINDING PROTEIN; PEROXISOMAL BIOGENENSIS FACTOR 5 LIKE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN LYSINE 6 OXIDASE; PROTEIN RAD54B; UNCLASSIFIED DRUG;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HEARING; HEARING LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RNA EXTRACTION;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 3; DNA; FEMALE; GENE EXPRESSION; GENES, NEOPLASM; GENOME, HUMAN; HEARING; HEARING LOSS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROMA, ACOUSTIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 68849108589     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181a66ece     Document Type: Article

References (44)

1. Eckermeier L, Pirsig W, Mueller D. Histopathology of 30 nonoperated acoustic schwannomas. Arch Otorhinolaryngol 1979; 222:1-9.
2. Kaga K, Iwasaki S, Tamura A, Suzuki J, Haebara H. Temporal bone pathology of acoustic neuroma correlating with presence of electrocochleography and absence of auditory brainstem response. J Laryngol Otol 1997;111:967-972
3. Nadol JB Jr, Diamond PF, Thornton AR. Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic neuromas). Am J Otol 1996;17:312-316
4. Mahmud MR, Khan AM, Nadol JB Jr. Histopathology of the inner ear in unoperated acoustic neuroma. Ann Otol Rhinol Laryngol 2003;112:979-986
5. Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang LS. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002;23:736-748
6. Lasak JM, Welling DB, Akhmametyeva EM, Salloum M, Chang LS. Retinoblastoma-cyclinYdependent kinase pathway deregulation in vestibular schwannomas. Laryngoscope 2002;112:1555-1561
7. GenePattern 3.0.Available at: http://www.broad.mit.edu/genepattern/. Accessed December 2007.
8. Stankovic KS, Goldsztein H, Reh DD, Platt MP, Metson R. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope 2008;118: 881-889
9. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537
10. Gould J, Getz G, Monti S, Reich M, Mesirov JP. Comparative gene marker selection suite. Bioinformatics 2006;22:1924-1925
11. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-15550
12. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman & Hall, 1993.
13. Hung G, Colton J, Fisher L, et al. Immunohistochemistry study of human vestibular nerve schwannoma differentiation. Glia 2002; 38:363-370
14. Chedrawi A, Clark G. Peroxisomal disorders. eMedicine. Available at: http://emedicine.medscape.com/article/1177387-overview. Accessed December 2008.
15. Maurer AM, Zhou B, Han ZC. Roles of platelet factor 4 in hematopoiesis and angiogenesis. Growth Factors 2006;24:242-252
16. Martin EW, Kibbey WE, di Vecchia L, Anderson G, Catalano P, Minton JP. Carcinoembryonic antigen: clinical and histological aspects. Cancer 1976;37:62-81.
17. Amery L, Sano H, Mannaerts GP, et al. Identification of PEX5prelated novel peroxisome-targeting signal 1 (PTS1)-binding proteins in mammals. Biochem J 2001;357:635-646
18. Starr A, Michalewski HJ, Zeng FG, et al. Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145->Ser). Brain 2003;126:1604-1619
19. Kilfoyle DH, Dyck PJ, Wu Y, et al. Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:963-966
20. Ionasescu VV, Searby C, Greenberg SA. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene. J Med Genet 1996;33:1048-1049
21. Minor LB, Haslwanter T, Straumann D, Zee DS. Hyperventilationinduced nystagmus in patients with vestibular schwannoma. Neurology 1999;53:2158-2168
22. Neely JG, Hough JV. Histologic findings in two very small intracanalicular solitary schwannomas of the eighth nerve: II. "Onion bulbs." Am J Otol 1988;9:216-221
23. Kanda T, Komatsuzaki A, Yaku Y. Histological changes of vestibular nerves and ganglion cells in the acoustic tumor in relation to clinical functions. Acta Otolaryngol Suppl 1991;481:97-102.
24. Antinheimo J, Sallinen SL, Sallinen P, et al. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir (Wien) 2000;142:1099-104; discussion 1104-1105
25. Warren C, James LA, Ramsden RT, et al. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 2003; 40:802-806
26. Hiramoto T, Nakanishi T, Sumiyoshi T, et al. Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer. Oncogene 1999;18:3422-3426
27. Sharan SK, Morimatsu M, Albrecht U, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997;386:804-810
28. Lopez-Casamichana M, Orozco E, Marchat LA, Lopez-Camarillo C. Transcriptional profile of the homologous recombination machinery and characterization of the EhRAD51 recombinase in response to DNA damage in Entamoeba histolytica. BMC Mol Biol 2008;9:35.
29. Christodoulopoulos G, Malapetsa A, Schipper H, Golub, et al. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia. Clin Cancer Res 1999;5:2178-2184
30. Solinger JA, Kiianitsa K, Heyer WD. Rad54, a Swi2/Snf2Ylike recombinational repair protein, disassembles Rad51:dsDNA filaments. Mol Cell 2000;10:1175-1188
31. O'Keefe DS, Bacich DJ, Heston WD. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostatespecific membrane antigen-like gene. Prostate 2004;58:200-210
32. Hlouchová K, Barinka C, Klusák V, et al. Biochemical characterization of human glutamate carboxypeptidase III. J Neurochem 2007;101:682-696
33. Slusher BS, Vornov JJ, Thomas AG, et al. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 1999;5:1396-1402
34. Ghadge GD, Slusher BS, Bodner A, et al. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc Natl Acad Sci U S A 2003;100:9554-9559
35. Twijnstra A, Nooyen WJ, van Zanten AP, et al. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases. Arch Neurol 1986;43:269-272
36. Jacobi C, Reiber H, Felgenhauer K. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid. J Neurol 1986;233:358-361
37. Flaschka G, Desoye G. CEA plasma levels in patients with intracranial tumours. Neurochirurgia (Stuttg) 1987;30:5-7.
38. Louis DN, Hamilton AJ, Sobel RA, Ojemann RG. Pseudopsammomatous meningioma with elevated serum carcinoembryonic antigen: a true secretory meningioma. Case report. J Neurosurg 1991; 74:129-132
39. Mochizuki H, Satoh S, Saikawa M, et al. A 74-year-old man with urinary incontinence, right leg weakness and multiple cranial nerve palsies. No To Shinkei 1995;47:199-209.
40. Kan S, Ikeda T. Gd-DTPA enhancement of cranial nerves on MR imaging. Neoplastic lesions. Acta Neurol Scand 1999;100:400-406
41. Miura M, Iijima N, Hayashida K, et al. Case of leptomeningeal carcinomatosis effectively treated with intrathecal chemotherapy using ventriculoperitoneal shunt. Rinsho Shinkeigaku 2006; 46:404-409
42. Shen Y, Blumenthal DT, Digre K, Cessna MH, Gopez EV. Carcinomatous meningitis as the presenting manifestation of gallbladder carcinoma: case report and review of the literature. J Neurooncol 2004;70:67-71.
43. Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN. Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J Biol Chem 2001;276:29681-29687
44. Labit-Bouvier C, Crebassa B, Bouvier C, et al. Clinicopathologic growth factors in vestibular schwannomas: a morphological and immunohistochemical study of 69 tumours. Acta Otolaryngol 2000;120:950-954